Universal Health Services Inc. ($UHS) Stock Forecast: Up 10.1% Today

What is Universal Health Services Inc.?

Universal Health Services Inc. Cl B (UHS) is a healthcare management company that operates acute care hospitals, behavioral health facilities, and ambulatory centers in the United States and the United Kingdom. Today, UHS experienced a strong bullish movement in the stock market.

Why is Universal Health Services Inc. going up?

UHS stock is up 10.1% on Feb 12, 2026 15:12

• UHS stock showed a 2.21% increase to $151.71, surpassing its competitors and trading above key moving averages, indicating a positive trend.
• Comparisons with HCA Healthcare reveal that investors may be drawn to UHS for its lower valuation and stronger revenue and operating income growth.
• Favorable sentiment towards healthcare stocks, exemplified by UHS, may stem from market attention on the sector's resilience and growth outlook amid global health challenges.
• UHS's robust performance seems to align with broader market optimism, mirrored by the strong showings of other healthcare-related companies like Nektar Therapeutics and Universal Health Realty, suggesting an encouraging industry sentiment guiding investor attention towards healthcare stocks.

UHS Price Chart

UHS Technical Analysis

UHS News

Pay Less, Gain More: UHS Tops HCA Healthcare Stock

This article analyzes why Universal Health Services (UHS) stock may be a better investment than HCA Healthcare (HCA). It highlights that UHS has a lower valuation (P/OpInc) but higher revenue and operating income growth compared to HCA. The analysis also compares current metrics with those from a year prior, suggesting that HCA's underperformance in growth metrics reinforces the conclusion that its stock is expensive.

https://www.trefis.com/stock/hca/articles2/590549/pay-less-gain-more-uhs-tops-hca-healthcare-stock/2026-02-12

Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day

Universal Health Services Inc. Cl B (UHS) stock saw a strong performance, rising 2.21% to $151.71, outpacing competitors. The stock also traded above its 50-day and 200-day moving averages, indicating a positive trend. Volume increased significantly compared to its 50-day average.

https://www.msn.com/en-us/money/topstocks/universal-health-services-inc-cl-b-stock-outperforms-competitors-on-strong-trading-day/ar-AA1W9Orw?ocid=finance-verthp-feeds

Nektar Therapeutics stock hits 52-week high at 66.97 USD

Nektar Therapeutics (NKTR) stock surged to a 52-week high of $66.97, representing a nearly tenfold increase from its annual low and a 462.93% return over the past year. This comes despite the company not being profitable, although it boasts strong gross profit margins and a healthy current ratio. Recent positive developments, including a $300 million stock offering and promising long-term data for its atopic dermatitis treatment, have led to analyst upgrades and increased price targets.

https://www.investing.com/news/company-news/nektar-therapeutics-stock-hits-52week-high-at-6697-usd-93CH-4500722

Universal Health Realty (UHT) Delivers Steady Income with Four Decades of Dividend Growth

Universal Health Realty Income Trust (UHT) provides steady income, boasting 42 consecutive years of dividend growth, albeit at a modest average rate of 1.5% annually. The REIT, structured around medical office properties and managed by its largest tenant, Universal Health Services, prioritizes current income for investors due to its high yield and dependable, slow growth. Although recent Q3 2025 results included some one-time gains and declines, the company continues to focus on its diverse healthcare facility portfolio.

https://www.insidermonkey.com/blog/universal-health-realty-uht-delivers-steady-income-with-four-decades-of-dividend-growth-1693522/

Amkor Technology stock hits 52-week high at $55.25

Amkor Technology Inc. (NASDAQ: AMKR) has reached a new 52-week high of $55.25, with its current stock price at $55.42. The semiconductor packaging and test services provider has seen a 1-year return of 151.08% and a 132.21% gain over the past six months, reflecting strong investor confidence and market position. This surge follows robust financial results for Q4 2025, beating EPS and revenue expectations, and a raised price target from Needham to $65.

https://www.investing.com/news/company-news/amkor-technology-stock-hits-52week-high-at-5525-93CH-4500283

Trending Today

Ethereum ($ETH) Crypto Forecast: Down 5.0% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Down 10.2% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Down 5.6% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Down 8.6% Today

Akamai Technologies Inc. ($AKAM) Stock Forecast: Up 5.1% Today

Hewlett Packard Enterprise Company ($HPE) Stock Forecast: Down 5.5% Today

Fifth Third Bancorp ($FITB) Stock Forecast: Down 5.5% Today

Crowdstrike Holdings Inc. ($CRWD) Stock Forecast: Down 8.2% Today

International Business Machines Corporation ($IBM) Stock Forecast: Down 12.4% Today

Accenture plc Class A (Ireland) ($ACN) Stock Forecast: Down 5.6% Today

Universal Health Services Inc. Price History

28.09.2025 - UHS Stock was up 3.4%

• UHS stock reached a 52-week high today, surpassing Q3 earnings and revenue estimates, and demonstrating fast-paced momentum.
• The company's strong performance can be attributed to consistently beating earnings estimates, impressive fundamentals, and being attractively priced for investors.
• Investor optimism about UHS's future potential is evident from the positive reactions to its financial results and growth prospects.
• The market movement reflects confidence in UHS's ability to deliver strong performance and maintain its growth trajectory in the healthcare industry.

31.11.2025 - UHS Stock was down 2.8%

• The bearish movement in UHS stock today can be attributed to several factors:
• Texas Permanent School Fund Corp significantly reducing its stake in UHS by 59.8% in Q2 might have signaled to other investors a lack of confidence in the company's future prospects.
• Despite the strong quarterly earnings report, the consensus rating of "Hold" by brokerages and the mixed price targets could have led to uncertainty among investors, causing some to sell off their positions.
• The increase in institutional ownership, with Osaic Holdings Inc. acquiring a substantial number of shares, could indicate conflicting sentiments within the market, leading to a lack of clear direction for the stock price.
• The focus on key financial metrics by health system leaders may have also influenced investor sentiment towards healthcare companies like UHS, especially in a dynamic and competitive industry landscape.

11.01.2026 - UHS Stock was up 4.5%

• UHS stock likely experienced a bullish movement due to being identified as one of the medical stocks poised to exceed fourth-quarter earnings expectations.
• The company's positive outlook can be attributed to strengthened outpatient volumes, higher admissions, and the adoption of tech-enabled services, which have contributed to its financial success.
• The strong performance of Encompass Health Corp. in the healthcare sector may have also positively influenced investor sentiment towards UHS, indicating a broader positive trend in the industry.
• Overall, UHS's bullish movement today could be a result of investors anticipating strong financial results and growth prospects for the company in the upcoming quarter.

24.09.2025 - UHS Stock was up 1.7%

• Impressive Q3 earnings were reported by UHS, surpassing expectations and boosting investor confidence in the company's performance.
• Focusing on key metrics in the earnings report provided a deeper insight into UHS's operational efficiency and financial health, further supporting the bullish market movement.
• Investors are optimistic about UHS's potential growth and performance, leading to increased buying interest and driving the stock price higher.

29.06.2025 - UHS Stock was up 5.2%

• UHS stock experienced a bullish movement.
• The company reported strong Q2 earnings, surpassing earnings per share (EPS) and revenue estimates.
• Despite concerns about the behavioral health segment, UHS raised its FY25 EPS guidance and EBITDA forecast, showing positive growth prospects.
• The market reacted positively to the earnings and guidance, leading to the bullish movement in UHS stock.

07.00.2026 - UHS Stock was down 5.0%

• The Outpatient Clinics Market is set to expand, potentially signaling heightened competition in the healthcare sector.
• A federal judge's ruling pausing the new 340B drug rebate program might have impacted UHS's revenue outlook.
• Despite solid quarterly earnings, institutional selling by Virginia Retirement Systems Et Al could have played a role in the stock's downturn.
• UHS's weaker performance against competitors during a general market decline indicates specific internal factors affecting its stock value.

07.00.2026 - UHS Stock was down 7.0%

• The bearish movement in UHS stock could be attributed to concerns over the potential non-extension of Affordable Care Act subsidies, leading to a cut in fiscal year 2026 adjusted EBITDA estimates.
• Despite the lowered price target, there is still an upside potential of 11%, indicating some optimism in the stock.
• The projected boom in the Outpatient Clinics Market could indirectly impact UHS as it operates in the healthcare sector, potentially creating competitive pressures or shifting dynamics within the industry.
• Discussion around debt management strategies in the healthcare sector might influence investor sentiment towards companies like UHS with regards to their balance sheet strength.

05.01.2026 - UHS Stock was up 5.1%

• UHS experienced a strong bullish movement today, likely driven by positive market sentiment and investor confidence in the company's growth prospects.
• The focus on sales growth as a reliable indicator of underlying momentum and potential for future earnings aligns with UHS's strategic direction, reinforcing investor belief in the company's ability to deliver strong financial results.
• The leadership reset and activist pressure on competitor Acadia Healthcare (ACHC) may have also indirectly benefited UHS, as investors seeking stability and strategic actions in the healthcare sector may have turned to UHS as a more promising investment option.

29.09.2025 - UHS Stock was up 5.4%

• UHS saw a significant 53% year-over-year surge in earnings per share in Q3, fueled by higher admissions and improved patient days, leading to a positive reaction from investors.
• Management's decision to increase its 2025 EPS forecast to $21.50-$22.10 has enhanced trust in UHS's future outlook.
• UHS exceeded Q3 earnings and revenue expectations by a sizable margin, demonstrating robust operational performance and financial stability, likely driving the stock's upward trend.
• Despite reaching a 52-week high, UHS remains attractively priced, making it an appealing option for investors seeking stocks with strong momentum at reasonable valuations.

29.06.2025 - UHS Stock was up 3.8%

• UHS surpassed Q2 earnings and revenue estimates by +10.31% and +1.51% respectively, showcasing robust financial performance.
• The company's gains from hospital and behavioral health services were key drivers of its positive results.
• Although there were worries about increasing costs impacting earnings, UHS outperformed expectations, prompting the bullish market trend.
• Investors hold a positive outlook on UHS's future potential, buoyed by its strong Q2 showing and anticipated growth in critical metrics.

11.01.2026 - UHS Stock was up 8.4%

• UHS stock likely saw a bullish movement due to the overall positive sentiment in the healthcare sector, as evidenced by other companies hitting a 52-week high and reporting strong fourth-quarter earnings.
• The anticipation of UHS exceeding fourth-quarter earnings expectations, as mentioned in sources highlighting medical stocks ready to deliver a Q4 beat, could have contributed to the bullish movement.
• Analyst upgrades and increased price targets for another company following recent positive developments might have spilled over to positively impact UHS stock as well.
• The healthcare sector's resilience in the face of challenges like rising medical costs and wage inflation could have instilled confidence in investors, leading to the bullish movement in UHS stock.

12.01.2026 - UHS Stock was up 10.1%

• UHS stock showed a 2.21% increase to $151.71, surpassing its competitors and trading above key moving averages, indicating a positive trend.
• Comparisons with HCA Healthcare reveal that investors may be drawn to UHS for its lower valuation and stronger revenue and operating income growth.
• Favorable sentiment towards healthcare stocks, exemplified by UHS, may stem from market attention on the sector's resilience and growth outlook amid global health challenges.
• UHS's robust performance seems to align with broader market optimism, mirrored by the strong showings of other healthcare-related companies like Nektar Therapeutics and Universal Health Realty, suggesting an encouraging industry sentiment guiding investor attention towards healthcare stocks.